Xencor Inc Business Operations Contracts & Agreements
15 Contracts & Agreements
- Collaboration Agreements (8 contracts)
- Development Agreements (3)
- Sales Agreements (1)
- Services Agreements (1)
- Supply Agreements (2)
- First Amendment to Collaboration and License Agreement, dated January 30, 2023, by and between the Company and Janssen Biotech, Inc (Filed With SEC on August 3, 2023)
- Second Amendment to the Collaboration and License Agreement, dated June 30, 2021, by and between the Company and Genentech, Inc., and F. Hoffmann-La Roche LTD (Filed With SEC on August 4, 2021)
- First Amendment to the Collaboration and License Agreement, dated March 10, 2021, by and between the Company and Genentech, Inc. and F. Hoffmann-La Roche LTD (Filed With SEC on May 5, 2021)
- AMENDMENT NO. 1 TO COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on November 2, 2016)
- FIRST AMENDMENT TO GPEx®-DERIVED CELL LINE SALES AGREEMENT (Filed With SEC on August 5, 2015)
- Master Services Agreement (Filed With SEC on February 20, 2015)
- DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT (Filed With SEC on November 4, 2013)
- DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT (Filed With SEC on October 25, 2013)
- CLINICAL SUPPLY AGREEMENT (Filed With SEC on October 25, 2013)
- COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on October 25, 2013)
- COLLABORATION AND OPTION AGREEMENT (Filed With SEC on October 25, 2013)
- CLINICAL SUPPLY AGREEMENT (Filed With SEC on October 11, 2013)
- COLLABORATION AND OPTION AGREEMENT (Filed With SEC on October 11, 2013)
- COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on October 11, 2013)
- DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT (Filed With SEC on October 11, 2013)
